$54.48
Ingevity Corp (NGVT) is a publicly traded specialty chemicals business based in the US which employs around 1,700 staff. Ingevity is listed on the NYSE and traded in US dollars. Its current price of $54.48 is 16.2% up on its price a month ago ($46.88).
How to buy shares in Ingevity
- Choose a platform. If you're a beginner, our share trading platform picks below can help you choose.
- Open your account. Provide your personal information and sign up.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: NGVT in this case.
- Research shares. The platform should provide the latest information available.
- Buy your shares. Place a market order or limit order with your preferred number of shares. It's that simple.
Our top picks for where to buy Ingevity shares
- Commission-free stock trades
- Receive dividend payments
- Invest in fractional shares
- Commission-free trading
- Invest in fractional shares
- Over 5,400 stocks & ETFs
- No commissions for funds
- Expert research and insights
- Wide range of tax wrappers
Fees calculator for buying Ingevity shares with popular apps
Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.
Quantity of shares
Platform | Finder score | Account fee | Min. initial deposit | Trade cost | Link |
---|---|---|---|---|---|
4.39 ★★★★★ |
£0 | $100 |
£524.57 |
Go to siteCapital at risk
|
|
3.75 ★★★★★ |
0.12% per year | £0 |
£523.41 |
Go to siteCapital at risk
|
|
4.3 ★★★★★ |
£0 | £0 |
£524.57 |
Go to siteCapital at risk
|
|
4.4 ★★★★★ |
£0 | £0 |
£524.57 |
Go to siteCapital at risk
|
|
4.2 ★★★★★ |
£0 | £1 |
£539.13 |
Go to siteCapital at risk
|
|
4.34 ★★★★★ |
0% - 0.25% | £100 |
N/A |
Go to siteCapital at risk
|
|
4.1 ★★★★★ |
£0 | £0 |
N/A |
Read reviewCapital at risk
|
Full comparison of share dealing platforms
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Alternative ways to invest in Ingevity
Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Ingevity), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.
Ingevity is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).
Is it a good time to buy Ingevity stock?
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Share price volatility
Over the last 12 months, Ingevity's shares have ranged in value from as little as $36.66 up to $66.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Ingevity's is 1.85. This would suggest that Ingevity's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Historical closes compared with the last close of $54.48
1 week (2024-05-02) | |
---|---|
1 month (2024-04-10) | |
3 months (2024-02-08) | |
6 months (2023-11-09) | |
1 year (2023-05-09) | |
2 years (2022-05-10) | |
3 years (2021-05-10) | |
5 years (2019-05-09) |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
- Start investing from $50
- Pay no stamp duty on UK shares
- Commission-free trading. Other fees may apply.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Ingevity under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Ingevity P/E ratio, PEG ratio and EBITDA
Ingevity's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.05. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Ingevity's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Ingevity's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $359.8 million (£0.0 million).
The EBITDA is a measure of a Ingevity's overall financial performance and is widely used to measure a its profitability.
Sign up for weekly expert share tips
Join 100,000 subscribers who are notified about expert share tips. Plus a chance to win £800!
By signing up you agree to receive emails from Finder and to the privacy policy and terms & conditions.
Frequently asked questions
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
More guides on Finder
-
How to buy SPDR FTSE UK All Share UCITS ETF Acc
Ever wondered how to invest in FTAL ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
-
How to buy Franklin FTSE United Kingdom ETF
Ever wondered how to invest in FLGB ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
-
How to buy HSBC FTSE 100 UCITS ETF
Ever wondered how to invest in HUKX ETF? Learn more about it now and find out where you can invest in it. Compare ETF brokers to start investing today.
-
How to buy Flutter Entertainment shares
Thinking about buying shares in Flutter Entertainment? We explain how to do it and compare a range of providers who will give you access to global markets.
-
How to buy Dettol shares | 4597p
Sales of Reckitt Bencksier products like Dettol have risen due to coronavirus. Here’s how you can invest in Dettol, by buying Reckitt Benckiser shares.
-
How to buy AT&T shares
Ever wondered how to buy shares in AT&T? We explain how and compare a range of providers that can give you access to many brands, including AT&T.
-
How to buy Wincanton shares
Ever wondered how to buy shares in Wincanton? We explain how and compare a range of providers that can give you access to many brands, including Wincanton.
-
How to buy United Utilities Group shares
Ever wondered how to buy shares in United Utilities? We explain how and compare a range of providers that can give you access to many brands, including United Utilities.
-
How to buy Relx shares
Find out how to buy shares in RELX, see its share prices over the last three months and check out our must-do checklist if you’re looking to invest.
-
How to buy Reach shares
Ever wondered how to buy shares in Reach? We explain how and compare a range of providers that can give you access to many brands, including Reach.